A study of the binding requirements of calyculin A and dephosphonocalyculin A with PP1, development of a molecular recognition model for the binding interactions of the okadaic acid class of compounds with PP1

European Journal of Pharmaceutical Sciences

Volumn 12, Issue 3, 2001, Pages 181-194

  Volter, Katie E ^a   Embrey, Kevin J ^a   Pierens, Gregory K ^a   Quinn, Ronald J ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

Calyculin A; Dephosphonocalyculin A; Microcystin; Nodularin; Okadaic acid; Protein phosphatases

Indexed keywords

CALYCULIN A; DEPHOSPHONOCALYCULIN A; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CRYSTAL STRUCTURE; DRUG BINDING SITE; DRUG CONFORMATION; DRUG PROTEIN BINDING; ENZYME CONFORMATION; MOLECULAR MODEL; MOLECULAR RECOGNITION; PHARMACOPHORE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

EID: 0033669246     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(00)00116-0     Document Type: Article

References (55)

1. Solution structure of nodularin; an inhibitor of serine/threonine specific protein phosphatases
2. A molecular basis for different interactions of marine toxins with protein phosphatase 1-molecular models for bound motuporin, microcystins, okadaic acid and calyculin A
3. Comparison of the solution structures of microcystin-LR and motuporin
4. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases
5. Isolation of calyculins, calyculinamides and swinholide H from the New Zealand deep-water marine sponge Larnellomorpha strongylata
6. Crystal structure of the catalytic subunit of human protein phosphatase I and its complex with tungstate
7. Solvent-dependent conformation and hydrogen-bonding capacity of cyclosporin A: Evidence from partition coefficients and molecular dynamics solutions
8. Isotope-edited NMR of cyclosporin A bound to cyclophilin: Evidence for a trans 9,10 amide bond
9. 13C]cyclosporin A bound to cyclophilin: Bound conformation and portions of cyclosporin involved in binding
10. Specific mechanistic aspects of animal tumor promoters: The okadaic acid pathway
11. A molecular modeling analysis of the binding interactions between the okadaic acid class of natural product inhibitors and the Ser-Thr phosphatases, PP1 and PP2A
12. Three-dimensional structure of the catalytic subunit of protein serine/threonine phosphatase-1
13. A model of binding of structurally diverse natural product inhibitors of protein phosphatases, PP1 and PP2A
14. Effects of a protein phosphates inhibitor, okadaic acid, on membrane currents of isolated guinea-pig cardiac myocytes
15. Characterisation of microcystin-LR, a potent inhibitor of Type 1 and Type 2A protein phosphatases0
16. Site-directed mutagenesis of amino acid residues of protein phosphatase 1 involved in catalysis and inhibitor binding
17. Calyculin A and okadaic acid: Inhibitors of protein phosphatase activity
18. Structure of human cyclophilin and its binding site for cyclosporin A determined by X-ray crystallography and NMR spectroscopy
19. Calyculin A, a novel antitumor metabolite from the marine sponge Discodermia calyx
20. Isolation and structure elucidation of calyculins B, C and D, novel antitumor metabolites, from the marine sponge Discodermia calyx
21. 6 by a combination of homo- and heteronuclear two-dimensional techniques
22. Complexation and medium effects on the conformation of cyclosporin a studied by nmr spectroscopy and molecular dynamics calculations
23. Reinvestigation of the conformation of cyclosporin A in chloroform
24. Conformation of cyclosporin A in polar solvents
25. Computer modelling of the 3-dimensional structures of the cyanobacterial hepatotoxins microcystin-LR and nodularin
26. Calculating three-dimensional molecular structure from atom-atom distance information: Cyclosporin A
27. Molecular dynamics simulations of cyclosporin A: The crystal structure and dynamic modeling of a structure in apolar solution based on NMR data
28. On the dependence of molecular conformation on the type of solvent environment: A molecular dynamics study of cyclosporin A
29. The binding mode of calyculin A to protein phosphatase-1
30. The conformation of cyclosporin A in the crystal and in solution
31. Conformational analysis of natural products using long-range carbon-proton coupling constants: Three-dimensional structure of okadaic acid in solution
32. Calyculins E, F, G, and H, additional inhibitors of protein phosphatases 1 and 2A, from the marine sponge Discodermia calyx
33. Isolation of dephosphonocalyculin A from the marine sponge, Discodermia calyx
34. Isolation of four new calyculins from the marine sponge Discodermia calyx
35. Inhibition of protein phosphatase 2A by cantharidin analogues
36. X-ray structure of a monomeric cyclophilin A-cyclosporin A crystal complex at 2.1°A resolution
37. The conserved acid binding domain pharmacophore model of inhibitors of protein phosphatases 1 and 2A: Molecular modelling aspects
38. Molecular modeling of microcystins
39. Apparent 'activation' of protein kinases by okadaic acid class tumor promoters
40. Protein phosphatases: Recent progress
41. Inhibition of the Ser-Thr phosphatases PP1 and PP2A by naturally occurring toxins
42. Determination of the NMR solution structure complex of the cyclophilin-cyclosporin A complex
43. Calyculin A, an inhibitor of protein phosphates, a potent tumor promoter on CD-1 mouse skin
44. Okadaic acid: An additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter
45. Specific binding of okadaic acid, a new tumor promoter in mouse skin
46. Okadaic acid, a cytotoxic polyether from two marine sponges of the Genus Halichondria
47. An alternative computer model of the 3-dimensional structures of microcystin-LR and nodularin rationalising their interactions with protein phosphatases 1 and 2A
48. Solution structure of cyclosporin A/cyclophilin complex by NMR
49. Conformational studies of microcystin-LR using NMR spectroscopy and molecular dynamics calculations
50. Conformational study of cyclosporin A in acetone at low temperature
51. The solution structures of calyculin A and dephosphonocalyculin A by NMR
52. The NMR structure of cyclosporin A bound to cyclophilin in aqueous solution
53. Serine/threonine protein phosphatases
54. Receptor-induced conformation change of the immunosuppressant cyclosporin A
55. Inhibition of protein phosphatases by microcystin and nodularin associated with hepatotoxicity